Product Information

MESALAMINE DR 400 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.5193 per EA under NDC 00093590786. Its NADAC has been published 384 times since Jul 17, 2019.

FDA first approved this application on May 9, 2019.

MESALAMINE DR 400 MG CAPSULE

Mesalamine
$2.5193per EA

Strength

400 mg/1

NDC

00093590786

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MESALAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207873

FDA Approved

5/9/2019

On Market Since

5/9/2019

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price Statistics

The NADAC for MESALAMINE DR 400 MG CAPSULE has been published 384 times since Jul 17, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$2.5193 per EA
All-time high$2.6990 (Oct 14, 2026)
All-time low$1.5286 (Jul 17, 2024)
52-week high$2.6990
52-week low$2.0896
Median price$2.1208
Average price$2.1290
Largest weekly change+29.8% (Aug 21, 2024)
Weeks tracked384
Tracking sinceJul 17, 2019

Price History

1W

-4.5%

1M

-4.5%

3M

-1.8%

6M

+4.7%

1Y

+13.6%

3Y

+16.8%

5Y

+11.6%

All

-1.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MESALAMINE DR 400 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 400 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.5193 per EA (NDC 00093590786), effective Nov 18, 2026.

How has the price of MESALAMINE DR 400 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MESALAMINE DR 400 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 384 weekly CMS publications since Jul 17, 2019.

What are the highest and lowest recorded NADAC prices for MESALAMINE DR 400 MG CAPSULE?

Since Jul 17, 2019, the NADAC for MESALAMINE DR 400 MG CAPSULE has ranged from a low of $1.5286 (Jul 17, 2024) to a high of $2.6990 (Oct 14, 2026), with a median of $2.1208 per EA.

Are there cheaper alternatives to MESALAMINE DR 400 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MESALAMINE DR 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures MESALAMINE DR 400 MG CAPSULE?

MESALAMINE DR 400 MG CAPSULE (NDC 00093590786) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.